Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1/1b Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors

NCT04374877 is registered in ClinicalTrials.gov with Coherus Oncology, Inc. as lead sponsor.

NCT NCT04374877
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04374877 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1/1b Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors
Lead sponsor
Coherus Oncology, Inc.
Phase
Phase 1
Overall status
Completed
Start date
April 22, 2020
Completion date
June 5, 2025
Enrollment
145 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumor, clear cell renal cell carcinoma, hepatocellular carcinoma, non-small cell lung cancer